drugset / Trial / NCT00006362

PS-341 in Treating Patients With Advanced Cancer

NCT00006362 ↗

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of PS-341 in treating patients who have advanced cancer.

Timeline

Start
1999-11
Primary completion
2003-08
Completion
2003-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Bortezomib Small molecule — Intravenous